APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Kidney Transplant Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Kidney Transplant Medicine Market Outlook and Growth Opportunities 2026

23 December 2025191 pages

Choose your research edition.

Industry ResearchKidney Transplant Medicine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Transplant Medicine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Kidney Transplant Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Transplant Medicine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Transplant Medicine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Kidney Transplant Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Kidney Transplant Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Kidney Transplant Medicine market include Sanofi, Novartis, Pfizer, GlaxoSmithKline plc, Veloxis Pharmaceuticals, Roche Pharmaceuticals, Prometheus Laboratories, Mayne Pharma Group Limited and Hansa Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Kidney Transplant Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Kidney Transplant Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Kidney Transplant Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Kidney Transplant Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Kidney Transplant Medicine Segment by Company

Sanofi

Novartis

Pfizer

GlaxoSmithKline plc

Veloxis Pharmaceuticals

Roche Pharmaceuticals

Prometheus Laboratories

Mayne Pharma Group Limited

Hansa Biopharma

BHARAT SERUM

Astellas Pharma

Kidney Transplant Medicine Segment by Type

Tacrolimus

Mycophenolate

Azathioprine

Ciclosporin

Other

Kidney Transplant Medicine Segment by Application

Online Sales

Offline Sales

Kidney Transplant Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Kidney Transplant Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Kidney Transplant Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Kidney Transplant Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Kidney Transplant Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Transplant Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Transplant Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Transplant Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Kidney Transplant Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Kidney Transplant Medicine industry.

Chapter 3: Detailed analysis of Kidney Transplant Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Kidney Transplant Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Kidney Transplant Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Kidney Transplant Medicine Industry Trends Table 2. Kidney Transplant Medicine Industry Drivers Table 3. Kidney Transplant Medicine Industry Opportunities and Challenges Table 4. Kidney Transplant Medicine Industry Restraints Table 5. Global Kidney Transplant Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Kidney Transplant Medicine Revenue Share by Company (2021-2026) Table 7. Global Kidney Transplant Medicine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Kidney Transplant Medicine Sales Volume Share by Company (2021-2026) Table 9. Global Kidney Transplant Medicine Average Price (USD/unit) of Company (2021-2026) Table 10. Global Kidney Transplant Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Kidney Transplant Medicine Key Company Manufacturing Base & Headquarters Table 12. Global Kidney Transplant Medicine Company, Product Type & Application Table 13. Global Kidney Transplant Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Kidney Transplant Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tacrolimus Table 18. Significant Companies of Mycophenolate Table 19. Significant Companies of Azathioprine Table 20. Significant Companies of Ciclosporin Table 21. Significant Companies of Other Table 22. Global Kidney Transplant Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Kidney Transplant Medicine Sales Volume by Type (2021-2026) & (k units) Table 24. Global Kidney Transplant Medicine Sales Volume by Type (2027-2032) & (k units) Table 25. Global Kidney Transplant Medicine Sales Volume Share by Type (2021-2026) Table 26. Global Kidney Transplant Medicine Sales Volume Share by Type (2027-2032) Table 27. Global Kidney Transplant Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Kidney Transplant Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Kidney Transplant Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Kidney Transplant Medicine Sales Value Share by Type (2021-2026) Table 31. Global Kidney Transplant Medicine Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Online Sales Table 33. Significant Companies of Offline Sales Table 34. Global Kidney Transplant Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Kidney Transplant Medicine Sales Volume by Application (2021-2026) & (k units) Table 36. Global Kidney Transplant Medicine Sales Volume by Application (2027-2032) & (k units) Table 37. Global Kidney Transplant Medicine Sales Volume Share by Application (2021-2026) Table 38. Global Kidney Transplant Medicine Sales Volume Share by Application (2027-2032) Table 39. Global Kidney Transplant Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Kidney Transplant Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Kidney Transplant Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Kidney Transplant Medicine Sales Value Share by Application (2021-2026) Table 43. Global Kidney Transplant Medicine Sales Value Share by Application (2027-2032) Table 44. Global Kidney Transplant Medicine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Kidney Transplant Medicine Sales by Region (2021-2026) & (k units) Table 46. Global Kidney Transplant Medicine Sales Market Share by Region (2021-2026) Table 47. Global Kidney Transplant Medicine Sales by Region (2027-2032) & (k units) Table 48. Global Kidney Transplant Medicine Sales Market Share by Region (2027-2032) Table 49. Global Kidney Transplant Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Kidney Transplant Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Kidney Transplant Medicine Sales Value Share by Region (2021-2026) Table 52. Global Kidney Transplant Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Kidney Transplant Medicine Sales Value Share by Region (2027-2032) Table 54. Global Kidney Transplant Medicine Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Kidney Transplant Medicine Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Kidney Transplant Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Kidney Transplant Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Kidney Transplant Medicine Sales by Country (2021-2026) & (k units) Table 59. Global Kidney Transplant Medicine Sales Market Share by Country (2021-2026) Table 60. Global Kidney Transplant Medicine Sales by Country (2027-2032) & (k units) Table 61. Global Kidney Transplant Medicine Sales Market Share by Country (2027-2032) Table 62. Global Kidney Transplant Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Kidney Transplant Medicine Sales Value Market Share by Country (2021-2026) Table 64. Global Kidney Transplant Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Kidney Transplant Medicine Sales Value Market Share by Country (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Sanofi Kidney Transplant Medicine Product Portfolio Table 70. Sanofi Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Novartis Kidney Transplant Medicine Product Portfolio Table 75. Novartis Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Pfizer Kidney Transplant Medicine Product Portfolio Table 80. Pfizer Recent Development Table 81. GlaxoSmithKline plc Company Information Table 82. GlaxoSmithKline plc Business Overview Table 83. GlaxoSmithKline plc Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. GlaxoSmithKline plc Kidney Transplant Medicine Product Portfolio Table 85. GlaxoSmithKline plc Recent Development Table 86. Veloxis Pharmaceuticals Company Information Table 87. Veloxis Pharmaceuticals Business Overview Table 88. Veloxis Pharmaceuticals Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Veloxis Pharmaceuticals Kidney Transplant Medicine Product Portfolio Table 90. Veloxis Pharmaceuticals Recent Development Table 91. Roche Pharmaceuticals Company Information Table 92. Roche Pharmaceuticals Business Overview Table 93. Roche Pharmaceuticals Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Roche Pharmaceuticals Kidney Transplant Medicine Product Portfolio Table 95. Roche Pharmaceuticals Recent Development Table 96. Prometheus Laboratories Company Information Table 97. Prometheus Laboratories Business Overview Table 98. Prometheus Laboratories Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Prometheus Laboratories Kidney Transplant Medicine Product Portfolio Table 100. Prometheus Laboratories Recent Development Table 101. Mayne Pharma Group Limited Company Information Table 102. Mayne Pharma Group Limited Business Overview Table 103. Mayne Pharma Group Limited Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Mayne Pharma Group Limited Kidney Transplant Medicine Product Portfolio Table 105. Mayne Pharma Group Limited Recent Development Table 106. Hansa Biopharma Company Information Table 107. Hansa Biopharma Business Overview Table 108. Hansa Biopharma Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Hansa Biopharma Kidney Transplant Medicine Product Portfolio Table 110. Hansa Biopharma Recent Development Table 111. BHARAT SERUM Company Information Table 112. BHARAT SERUM Business Overview Table 113. BHARAT SERUM Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. BHARAT SERUM Kidney Transplant Medicine Product Portfolio Table 115. BHARAT SERUM Recent Development Table 116. Astellas Pharma Company Information Table 117. Astellas Pharma Business Overview Table 118. Astellas Pharma Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Astellas Pharma Kidney Transplant Medicine Product Portfolio Table 120. Astellas Pharma Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Kidney Transplant Medicine Distributors List Table 124. Kidney Transplant Medicine Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Kidney Transplant Medicine Product Image Figure 2. Global Kidney Transplant Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Transplant Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Kidney Transplant Medicine Sales (2021-2032) & (k units) Figure 5. Global Kidney Transplant Medicine Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Kidney Transplant Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tacrolimus Image Figure 10. Mycophenolate Image Figure 11. Azathioprine Image Figure 12. Ciclosporin Image Figure 13. Other Image Figure 14. Global Kidney Transplant Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Kidney Transplant Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Kidney Transplant Medicine Sales Volume Share by Type (2021-2032) Figure 17. Global Kidney Transplant Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Kidney Transplant Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Kidney Transplant Medicine Sales Value Share by Type (2021-2032) Figure 20. Online Sales Image Figure 21. Offline Sales Image Figure 22. Global Kidney Transplant Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Kidney Transplant Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Kidney Transplant Medicine Sales Volume Share by Application (2021-2032) Figure 25. Global Kidney Transplant Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Kidney Transplant Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Kidney Transplant Medicine Sales Value Share by Application (2021-2032) Figure 28. Global Kidney Transplant Medicine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Kidney Transplant Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Kidney Transplant Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Kidney Transplant Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Kidney Transplant Medicine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Kidney Transplant Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Kidney Transplant Medicine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Kidney Transplant Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Kidney Transplant Medicine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Kidney Transplant Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Kidney Transplant Medicine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Kidney Transplant Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Kidney Transplant Medicine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Kidney Transplant Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Kidney Transplant Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Kidney Transplant Medicine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Kidney Transplant Medicine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Tacrolimus
  • Mycophenolate
  • Azathioprine
  • Ciclosporin
  • Other
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Sanofi
  • Novartis
  • Pfizer
  • GlaxoSmithKline plc
  • Veloxis Pharmaceuticals
  • Roche Pharmaceuticals
  • Prometheus Laboratories
  • Mayne Pharma Group Limited
  • Hansa Biopharma
  • BHARAT SERUM
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Kidney Transplant Medicine Sales Value (2021-2032)
  4. 1.2.2 Global Kidney Transplant Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global Kidney Transplant Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Kidney Transplant Medicine Market Dynamics
  1. 2.1 Kidney Transplant Medicine Industry Trends
  2. 2.2 Kidney Transplant Medicine Industry Drivers
  3. 2.3 Kidney Transplant Medicine Industry Opportunities and Challenges
  4. 2.4 Kidney Transplant Medicine Industry Restraints
3 Kidney Transplant Medicine Market by Company
  1. 3.1 Global Kidney Transplant Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Kidney Transplant Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Kidney Transplant Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Kidney Transplant Medicine Average Price by Company (2021-2026)
  5. 3.5 Global Kidney Transplant Medicine Company Ranking (2024-2026)
  6. 3.6 Global Kidney Transplant Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Kidney Transplant Medicine Company Product Type and Application
  8. 3.8 Global Kidney Transplant Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Kidney Transplant Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Kidney Transplant Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Kidney Transplant Medicine Market by Type
  1. 4.1 Kidney Transplant Medicine Type Introduction
  2. 4.1.1 Tacrolimus
  3. 4.1.2 Mycophenolate
  4. 4.1.3 Azathioprine
  5. 4.1.4 Ciclosporin
  6. 4.1.5 Other
  7. 4.2 Global Kidney Transplant Medicine Sales Volume by Type
  8. 4.2.1 Global Kidney Transplant Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Kidney Transplant Medicine Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Kidney Transplant Medicine Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Kidney Transplant Medicine Sales Value by Type
  12. 4.3.1 Global Kidney Transplant Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Kidney Transplant Medicine Sales Value by Type (2021-2032)
  14. 4.3.3 Global Kidney Transplant Medicine Sales Value Share by Type (2021-2032)
5 Kidney Transplant Medicine Market by Application
  1. 5.1 Kidney Transplant Medicine Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Kidney Transplant Medicine Sales Volume by Application
  5. 5.2.1 Global Kidney Transplant Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Kidney Transplant Medicine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Kidney Transplant Medicine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Kidney Transplant Medicine Sales Value by Application
  9. 5.3.1 Global Kidney Transplant Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Kidney Transplant Medicine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Kidney Transplant Medicine Sales Value Share by Application (2021-2032)
6 Kidney Transplant Medicine Regional Sales and Value Analysis
  1. 6.1 Global Kidney Transplant Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Kidney Transplant Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Kidney Transplant Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global Kidney Transplant Medicine Sales by Region (2027-2032)
  5. 6.3 Global Kidney Transplant Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Kidney Transplant Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Kidney Transplant Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Kidney Transplant Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global Kidney Transplant Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Kidney Transplant Medicine Sales Value (2021-2032)
  12. 6.6.2 North America Kidney Transplant Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Kidney Transplant Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe Kidney Transplant Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Kidney Transplant Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Kidney Transplant Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Kidney Transplant Medicine Sales Value (2021-2032)
  21. 6.9.2 South America Kidney Transplant Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Kidney Transplant Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Kidney Transplant Medicine Sales Value Share by Country, 2025 VS 2032
7 Kidney Transplant Medicine Country-level Sales and Value Analysis
  1. 7.1 Global Kidney Transplant Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Kidney Transplant Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Kidney Transplant Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global Kidney Transplant Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global Kidney Transplant Medicine Sales by Country (2027-2032)
  6. 7.4 Global Kidney Transplant Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Kidney Transplant Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Kidney Transplant Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Kidney Transplant Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Kidney Transplant Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Kidney Transplant Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Kidney Transplant Medicine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Kidney Transplant Medicine Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Kidney Transplant Medicine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline plc
  20. 8.4.1 GlaxoSmithKline plc Company Information
  21. 8.4.2 GlaxoSmithKline plc Business Overview
  22. 8.4.3 GlaxoSmithKline plc Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline plc Kidney Transplant Medicine Product Portfolio
  24. 8.4.5 GlaxoSmithKline plc Recent Developments
  25. 8.5 Veloxis Pharmaceuticals
  26. 8.5.1 Veloxis Pharmaceuticals Company Information
  27. 8.5.2 Veloxis Pharmaceuticals Business Overview
  28. 8.5.3 Veloxis Pharmaceuticals Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Veloxis Pharmaceuticals Kidney Transplant Medicine Product Portfolio
  30. 8.5.5 Veloxis Pharmaceuticals Recent Developments
  31. 8.6 Roche Pharmaceuticals
  32. 8.6.1 Roche Pharmaceuticals Company Information
  33. 8.6.2 Roche Pharmaceuticals Business Overview
  34. 8.6.3 Roche Pharmaceuticals Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Roche Pharmaceuticals Kidney Transplant Medicine Product Portfolio
  36. 8.6.5 Roche Pharmaceuticals Recent Developments
  37. 8.7 Prometheus Laboratories
  38. 8.7.1 Prometheus Laboratories Company Information
  39. 8.7.2 Prometheus Laboratories Business Overview
  40. 8.7.3 Prometheus Laboratories Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Prometheus Laboratories Kidney Transplant Medicine Product Portfolio
  42. 8.7.5 Prometheus Laboratories Recent Developments
  43. 8.8 Mayne Pharma Group Limited
  44. 8.8.1 Mayne Pharma Group Limited Company Information
  45. 8.8.2 Mayne Pharma Group Limited Business Overview
  46. 8.8.3 Mayne Pharma Group Limited Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mayne Pharma Group Limited Kidney Transplant Medicine Product Portfolio
  48. 8.8.5 Mayne Pharma Group Limited Recent Developments
  49. 8.9 Hansa Biopharma
  50. 8.9.1 Hansa Biopharma Company Information
  51. 8.9.2 Hansa Biopharma Business Overview
  52. 8.9.3 Hansa Biopharma Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hansa Biopharma Kidney Transplant Medicine Product Portfolio
  54. 8.9.5 Hansa Biopharma Recent Developments
  55. 8.10 BHARAT SERUM
  56. 8.10.1 BHARAT SERUM Company Information
  57. 8.10.2 BHARAT SERUM Business Overview
  58. 8.10.3 BHARAT SERUM Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 BHARAT SERUM Kidney Transplant Medicine Product Portfolio
  60. 8.10.5 BHARAT SERUM Recent Developments
  61. 8.11 Astellas Pharma
  62. 8.11.1 Astellas Pharma Company Information
  63. 8.11.2 Astellas Pharma Business Overview
  64. 8.11.3 Astellas Pharma Kidney Transplant Medicine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Astellas Pharma Kidney Transplant Medicine Product Portfolio
  66. 8.11.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Kidney Transplant Medicine Value Chain Analysis
  2. 9.1.1 Kidney Transplant Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Kidney Transplant Medicine Sales Mode & Process
  6. 9.2 Kidney Transplant Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Kidney Transplant Medicine Distributors
  9. 9.2.3 Kidney Transplant Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst